Searching journal content for articles similar to Templeman et al. 232 (3): R173.

Displaying results 1-10 of 635
For checked items
  1. ...and comparable phosphorylation of TBC1D1 at Thr590 confirm the muscle resistance phenotype that we have reported earlier (Gayen et  al. 2009). Fibrosis is increasingly appreciated as a major contributor to metabolic dysregulation in obese humans and type 2 diabetics, and increased expression of collagen...
  2. ..., whose understanding can be extended into treatment responses to facilitate targeted drug discovery for T2D and allied metabolic syndromes. Background Type 2 diabetes (T2D), obesity and allied disorders are posing serious health problems that are reaching epidemic proportions worldwide (Nanditha  et  al...
  3. ...and the metabolic syndrome. Physiology and Behavior 100 525–534. (doi:10.1016/j.physbeh.2010.03.018) DeFronzo RA & Tripathy D 2009 Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32 (Supplement 2) S157–S163. (doi:10.2337/dc09-S302) Deji N, Kume S, Araki S, Isshiki K, Araki...
  4. ...membrane, to increase the uptake of glucose (Cantó & Auwerx 2013). GLUT4 is an insulin-regulated protein that contributes to whole-body glucose homeostasis, and therefore, is a key target for understanding insulin resistance in type 2 diabetes mellitus (T2DM) (Teixeira et al. 2012). However...
  5. ...HFHS-fed rats. These data imply that the palatable component consumed plays a role in the development of site-specific insulin sensitivity. Introduction The prevalence of type 2 diabetes mellitus (T2DM), associated with obesity, is taking epidemic proportions. The molecular drivers involved in the pathogenesis...
  6. ... P & Harding R 2010 Induced preterm birth in sheep: a suitable model for studying the developmental effects of moderately preterm birth. Reproductive Sciences 17 724–733. (doi:10.1177/1933719110369182) DeFronzo RA & Tripathy D 2009 Skeletal muscle insulin resistance is the primary defect in type 2 diabetes...
  7. ...) and (B) glucagon (green). Insets show cells double labelled for the islet peptide and vimentin. (C, D) Islet from subject with type 2 diabetes (T2DM) labelled for vimentin (white) and (C) insulin (red) and (D) glucagon (green). Insets show cells double labelled for the islet peptide and vimentin. Scale...
  8. ...diabetes mellitus (T2DM), a condition resulting from the metabolic changes associated with excess fat. A pivotal role in T2DM development is played by insulin resistance (IR) that is the reduction of the response of peripheral target tissues to a physiological concentration of insulin. Skeletal muscle...
  9. ...proposed that during type 2 diabetes, MS and aging, GLUT4 expression is reduced in peripheral tissue, which may play a role in increasing insulin resistance (Shepherd & Kahn 1999, Gaster  et  al. 2001, Zeyda & Stulnig 2009). Moreover, some medical therapies for type 2 diabetes-like glitazones are able...
  10. ...because it causes several diseases and reduces life expectancy. Although it is well known that insulin resistance plays a pivotal role in the development of type 2 diabetes mellitus (the more frequent disease in obese people) the link between obesity and insulin resistance is yet a matter of debate. One...
For checked items